VERU INC. Foreign Currency Transaction Loss, before Tax
VERU INC. (VERU) reported Foreign Currency Transaction Loss, before Tax of $23.97 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2014-05-01
- VERU INC. foreign currency transaction loss, before tax for the quarter ending 2014-03-31 was $23.97K, a 19.10% decline year-over-year.
- VERU INC. foreign currency transaction loss, before tax for the quarter ending 2013-12-31 was $18.43K, a 50.56% decline year-over-year.
- VERU INC. foreign currency transaction loss, before tax for the quarter ending 2013-09-30 was $1.11K, a 98.59% decline year-over-year.
- VERU INC. foreign currency transaction loss, before tax for the quarter ending 2013-06-30 was $33.28K.
- VERU INC. foreign currency transaction loss, before tax for fiscal 2013 was $101.29K, a 31.69% decline from fiscal 2012.
- VERU INC. foreign currency transaction loss, before tax for fiscal 2012 was $148.27K, a 142.04% increase from fiscal 2011.
- VERU INC. foreign currency transaction loss, before tax for fiscal 2011 was $61.26K, a 60.27% decline from fiscal 2010.
- VERU INC. foreign currency transaction loss, before tax for fiscal 2010 was $154.20K.
| Period end | Foreign Currency Transaction Loss, before Tax 3 month | Foreign Currency Transaction Loss, before Tax 6 month | Foreign Currency Transaction Loss, before Tax 9 month | Foreign Currency Transaction Loss, before Tax 12 month |
|---|---|---|---|---|
| 2014-03-31 | $23.97K 10-Q · filed 2014-05-01 | $42.39K 10-Q · filed 2014-05-01 | $43.51K derived: sum of 3 quarters · filed 2014-05-01 | $76.79K derived: sum of 4 quarters · filed 2014-05-01 |
| 2013-12-31 | $18.43K 10-Q · filed 2014-02-03 | $19.54K derived: sum of 2 quarters · filed 2014-02-03 | $52.82K derived: sum of 3 quarters · filed 2014-02-03 | $82.45K derived: sum of 4 quarters · filed 2014-05-01 |
| 2013-09-30 | $1.11K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $34.40K derived: sum of 2 quarters · filed 2013-12-03 | $64.02K derived: sum of 3 quarters · filed 2014-05-01 | $101.29K 10-K · filed 2013-12-03 |
| 2013-06-30 | $33.28K 10-Q · filed 2013-08-01 | $62.91K derived: sum of 2 quarters · filed 2014-05-01 | $100.17K 10-Q · filed 2013-08-01 | $179.15K derived: sum of 4 quarters · filed 2014-05-01 |
| 2013-03-31 | $29.63K 10-Q · filed 2014-05-01 | $66.89K 10-Q · filed 2014-05-01 | $145.87K derived: sum of 3 quarters · filed 2014-05-01 | $130.63K derived: sum of 4 quarters · filed 2014-05-01 |
| 2012-12-31 | $37.27K 10-Q · filed 2014-02-03 | $116.24K derived: sum of 2 quarters · filed 2014-02-03 | $101.01K derived: sum of 3 quarters · filed 2014-02-03 | $133.23K derived: sum of 4 quarters · filed 2014-02-03 |
| 2012-09-30 | $78.97K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $63.74K derived: sum of 2 quarters · filed 2013-12-03 | $95.96K derived: sum of 3 quarters · filed 2013-12-03 | $148.27K 10-K · filed 2013-12-03 |
| 2012-06-30 | -$15.23K 10-Q · filed 2013-08-01 | $16.99K derived: sum of 2 quarters · filed 2013-08-01 | $69.29K 10-Q · filed 2013-08-01 | $56.30K derived: sum of 4 quarters · filed 2013-12-03 |
| 2012-03-31 | $32.22K 10-Q · filed 2013-05-02 | $84.53K 10-Q · filed 2013-05-02 | $71.54K derived: sum of 3 quarters · filed 2013-12-03 | $89.56K derived: sum of 4 quarters · filed 2013-12-03 |
| 2011-12-31 | $52.31K 10-Q · filed 2013-01-30 | $39.31K derived: sum of 2 quarters · filed 2013-12-03 | $57.34K derived: sum of 3 quarters · filed 2013-12-03 | $82.66K derived: sum of 4 quarters · filed 2013-12-03 |
| 2011-09-30 | -$12.99K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $5.03K derived: sum of 2 quarters · filed 2013-12-03 | $30.35K derived: sum of 3 quarters · filed 2013-12-03 | $61.26K 10-K · filed 2013-12-03 |
| 2011-06-30 | $18.02K 10-Q · filed 2012-07-31 | $43.34K derived: sum of 2 quarters · filed 2012-07-31 | $74.25K 10-Q · filed 2012-07-31 | $166.19K derived: sum of 4 quarters · filed 2012-07-31 |
| 2011-03-31 | $25.32K 10-Q · filed 2012-05-01 | $56.23K 10-Q · filed 2012-05-01 | $148.17K derived: sum of 3 quarters · filed 2012-05-01 | $130.98K derived: sum of 4 quarters · filed 2012-05-01 |
| 2010-12-31 | $30.91K 10-Q · filed 2012-01-31 | $122.84K derived: sum of 2 quarters · filed 2012-01-31 | $105.65K derived: sum of 3 quarters · filed 2012-01-31 | |
| 2010-09-30 | $91.94K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-02 | $74.75K derived: sum of 2 quarters · filed 2011-12-02 | $154.20K 10-K · filed 2011-12-02 | |
| 2010-06-30 | -$17.19K 10-Q · filed 2011-08-05 | $62.26K 10-Q · filed 2011-08-05 | ||
| 2009-09-30 | -$276.11K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |